SCHEMBL30734136

SCHEMBL30734136

Fc1ccc(C2CCN(c3ncnc4ccc(Br)cc34)CC2)c(F)c1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 7/20 0.55
NPSR1 Q6W5P4 2/20 0.52
ALDH1A1 P00352 1/20 0.52
CHRM4 P08173 1/20 0.48
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PDGFRB P09619 2/20 0.41
GRM2 Q14416 3/20 0.40
PAK1 Q13153 1/20 0.39
ACHE P22303 2/20 0.39
BACE1 P56817 2/20 0.39
ENPP1 P22413 1/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30734240 0.88 HTT (0.56) HTTNPSR1ALDH1A1CHRM4LMNA
SCHEMBL3848434 0.86 HTT (0.52) HTTNPSR1ALDH1A1CHRM4LMNA
SCHEMBL30734239 0.81 HTT (0.43) HTTALDH1A1CHRM4LMNASMN1; SMN2
SCHEMBL3844439 0.78 SLC2A1 (0.57) HTTNPSR1ALDH1A1LMNASMN1; SMN2
SCHEMBL3847712 0.78 HTT (0.61) HTTNPSR1ALDH1A1LMNASMN1; SMN2
SCHEMBL30734225 0.77 HTT (0.67) HTTNPSR1ALDH1A1LMNASMN1; SMN2
SCHEMBL3846839 0.76 STAT3 (0.61) HTTNPSR1ALDH1A1CHRM4HPGD
SCHEMBL29472072 0.75 HTT (0.76) HTTNPSR1ALDH1A1LMNASMN1; SMN2
SCHEMBL22715242 0.75 HTT (0.76) HTTNPSR1ALDH1A1LMNASMN1; SMN2
SCHEMBL3115181 0.74 HTT (0.74) HTTNPSR1ALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382301-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF UNIV ARIZONA (US) 2025-12-18 US disclosed
EP-4543888-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF Arizona Board of Regents on behalf of The University of Arizona (US) 2025-04-30 EP disclosed
WO-2023250083-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2023-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382301-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF CLK2, CLK3, CLK1 HTT 713/4885NPSR1 1834/4885ALDH1A1 4568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.